Skip to main content
. 2022 Nov 28;13:1024759. doi: 10.3389/fendo.2022.1024759

Table 1.

Univariate analysis of categorical variables.

Variables Total (N = 1,727) No readmission within 6 months (N = 1,065) Readmission within 6 months (N = 662) p-value No readmission within 3 months (N = 1,309) Readmission within 3 months (N = 418) p-value
Age (years) 0.117 0.103
 ≤59 154 (8.92%) 104 (9.77%) 50 (7.55%) 125 (9.55%) 29 (6.94%)
 >59 1,573 (91.08%) 961 (90.23%) 612 (92.45%) 1,184 (90.45%) 389 (93.06%)
Gender 0.413 0.868
 Male 717 (41.52%) 434 (40.75%) 283 (42.75%) 542 (41.41%) 175 (41.87%)
 Female 1,010 (58.48%) 631 (59.25%) 379 (57.25%) 767 (58.59%) 243 (58.13%)
NYHA class <0.001 <0.001
 II 297 (17.20%) 208 (19.53%) 89 (13.44%) 247 (18.87%) 50 (11.96%)
 III 910 (52.69%) 569 (53.43%) 341 (51.51%) 698 (53.32%) 212 (50.72%)
 IV 520 (30.11%) 288 (27.04%) 232 (35.05%) 364 (27.81%) 156 (37.32%)
Myocardial infarction 0.750 0.874
 No 1,600 (92.65%) 985 (92.49%) 615 (92.90%) 1,212 (92.59%) 388 (92.82%)
 Yes 127 (7.35%) 80 (7.51%) 47 (7.10%) 97 (7.41%) 30 (7.18%)
Congestive heart failure 0.812 0.230
 No 122 (7.06%) 74 (6.95%) 48 (7.25%) 87 (6.65%) 35 (8.37%)
 Yes 1,605 (92.94%) 991 (93.05%) 614 (92.75%) 1,222 (93.35%) 383 (91.63%)
Peripheral vascular disease 0.490 0.280
 No 1,641 (95.02%) 1,015 (95.31%) 626 (94.56%) 1,248 (95.34%) 393 (94.02%)
 Yes 86 (4.98%) 50 (4.69%) 36 (5.44%) 61 (4.66%) 25 (5.98%)
COPD 0.624 0.122
 No 1,524 (88.25%) 943 (88.54%) 581 (87.76%) 1,164 (88.92%) 360 (86.12%)
 Yes 203 (11.75%) 122 (11.46%) 81 (12.24%) 145 (11.08%) 58 (13.88%)
CCI score <0.001 <0.001
 0 1,322 (76.55%) 847 (79.53%) 475 (71.75%) 1,029 (78.61%) 293 (70.10%)
 1 405 (23.45%) 218 (20.47%) 187 (28.25%) 280 (21.39%) 125 (29.90%)
Diabetes <0.001 0.005
 No 1,326 (76.78%) 848 (79.62%) 478 (72.21%) 1,026 (78.38%) 300 (71.77%)
 Yes 401 (23.22%) 217 (20.38%) 184 (27.79%) 283 (21.62%) 118 (28.23%)

COPD, Chronic obstructive pulmonary disease; CCI, Charlson comorbidity index, 0: ≤2 points; 1: >2 points.